Hyojeong Moon

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry

Mayer Fishman, Janice P. Dutcher, Joseph I. Clark et al. · Journal for ImmunoTherapy of Cancer · 2019 · 46 citations · Full text

Medicine, Immunology, Oncology +16

Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson’s disease

Han Soo Yoo, Seok Jong Chung, Su Jin Chung et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 37 citations · Full text

Medicine, Neurology, Neuroscience +16

Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma

Seung Cheol Ha, Jungsu S. Oh, Jong‐Lyel Roh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 33 citations

Medicine, Oncology, Radiology +8

Postdiagnostic use of β-blockers and other antihypertensive drugs and the risk of recurrence and mortality in head and neck cancer patients: an observational study of 10,414 person–years of follow-up

S.-A. Kim, Hyojeong Moon, Jong‐Lyel Roh et al. · Clinical & Translational Oncology · 2017 · 32 citations

Medicine, Oncology, Pharmacotherapy +8

Risk Factors for Obesity Among Children Aged 24 to 80 months in Korea: A Decision Tree Analysis

In-Sook Lee, Kyung‐Sook Bang, Hyojeong Moon et al. · Journal of Pediatric Nursing · 2019 · 30 citations

Agriculture, Child Health, Nutrition +10